Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of OP-2024 in healthy male adults
jRCT2071230034Phase 1Completed
- Sponsor
- Ohara Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of XI Ning in Parkinson's disease (PD), sponsored by Ohara Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetics. Started Jul 2023; status: completed.
02
Drugs
XI Ning
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2071230034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230034.